Invention Grant
- Patent Title: Nasal administration
- Patent Title (中): 鼻管
-
Application No.: US14274271Application Date: 2014-05-09
-
Publication No.: US08875704B2Publication Date: 2014-11-04
- Inventor: Per Gisle Djupesland , Roderick Peter Hafner
- Applicant: Optinose AS
- Applicant Address: NO Oslo
- Assignee: Optinose AS
- Current Assignee: Optinose AS
- Current Assignee Address: NO Oslo
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: GB0706744.0 20070405
- Main IPC: A61M15/08
- IPC: A61M15/08 ; A61M16/00 ; A61M15/00 ; A61K31/4045 ; A61M16/08 ; A61M16/10

Abstract:
A delivery device for and method of delivering a powdered substance, in particular a triptan, such as sumatriptan, to the posterior region of a nasal cavity of a subject, in particular for the treatment of headaches, for example, cluster headaches and migraine, and neuropathic pain, the delivery device comprising: a nosepiece for insertion into a nasal cavity of a subject through which the powdered substance is delivered to the posterior region of the nasal cavity of the subject, in particular the upper posterior two thirds of the nasal cavity; and a substance supply unit which is operable to deliver the powdered substance through the nosepiece.
Public/Granted literature
- US20140246022A1 NASAL ADMINISTRATION Public/Granted day:2014-09-04
Information query